# Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis

> **NCT05750966** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 440 (estimated)

## Conditions studied

- Cholangitis

## Interventions

- **DRUG:** cefrtriaxone, gentamicin, cefuroxim, ciprofloxin or other antibiotics according to local guideline (24 hours)
- **DRUG:** cefrtriaxone, gentamicin, cefuroxim, ciprofloxin or other antibiotics according to local guideline (4 to 7 days)

## Key facts

- **NCT ID:** NCT05750966
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-19
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05750966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05750966, "Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05750966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*